Innovation Pharmaceuticals Inc (IPIX): In case you forgot, here are the seconda...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	56
Posts	5540
Boards Moderated	0
Alias Born	11/04/2011

sox040713

Re: To infinity and beyond! post# 144438

Wednesday, 04/06/2016 1:44:01 PM

Wednesday, April 06, 2016 1:44:01 PM

In case you forgot, here are the secondary endpoints of the Prurisol trial:

Secondary Outcome Measures:
-The Secondary efficacy endpoints are the percentage of subjects in each treatment group with:≥ 2 point improvement in IGA at 28 days [ Time Frame: 28 days ] [ Designated as safety issue: No ]
-The Secondary efficacy endpoints are the percentage of subjects in each treatment group with: ≥ 2 point improvement in IGA at 56 days [ Time Frame: 56 Days ] [ Designated as safety issue: No ]
-The Secondary efficacy endpoints are the percentage of subjects in each treatment group with: ≥1 point improvement in Scaling Score of Target Lesion at 28 days [ Time Frame: 28 Days ] [ Designated as safety issue: No ]
-The Secondary efficacy endpoints are the percentage of subjects in each treatment group with: ≥1 point improvement in Scaling Score of Target Lesion at 56 days [ Time Frame: 56 Days ] [ Designated as safety issue: No ]
-The Secondary efficacy endpoints are the percentage of subjects in each treatment group with: ≥1 point improvement in Scaling Score of Target Lesion at 84 days [ Time Frame: 84 Days ] [ Designated as safety issue: No ]

https://clinicaltrials.gov/ct2/show/NCT02494479?term=cellceutix&rank=2

FUD - Fear, uncertainty and doubt, is generally a strategic attempt to influence perception by disseminating negative and dubious or false information.